Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) — Capital Reinvestment Ratio
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a Capital Reinvestment Ratio of 0.95x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥45.11 Million) in capital expenditures (CN¥42.81 Million). See cash generation quality of Shandong Bailong Chuangyuan Bio-Tech Co. to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Capital Reinvestment Ratio (2016–2025)
This chart tracks Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. For live market cap and broader valuation context, see Shandong Bailong Chuangyuan Bio-Tech Co. (605016) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.19x | CN¥135.45 Million | CN¥296.80 Million | ▲ +134.0% |
| 2024 | 0.94x | CN¥300.89 Million | CN¥281.81 Million | ▼ -41.6% |
| 2023 | 1.60x | CN¥194.63 Million | CN¥311.98 Million | ▲ +36.8% |
| 2022 | 1.17x | CN¥149.82 Million | CN¥175.60 Million | ▲ +102.0% |
| 2021 | 0.58x | CN¥96.20 Million | CN¥55.82 Million | ▲ +20.5% |
| 2020 | 0.48x | CN¥121.82 Million | CN¥58.66 Million | ▼ -45.4% |
| 2019 | 0.88x | CN¥64.08 Million | CN¥56.49 Million | ▼ -10.8% |
| 2018 | 0.99x | CN¥89.12 Million | CN¥88.11 Million | ▲ +206.0% |
| 2017 | 0.32x | CN¥113.47 Million | CN¥36.66 Million | ▼ -30.8% |
| 2016 | 0.47x | CN¥60.10 Million | CN¥28.08 Million | — |